Therapy Areas: Cardiovascular
Myqorzo and Redemplo receive regulatory approval in China
15 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that China's National Medical Products Administration has approved two Sanofi-licen...
Cereno Scientific publishes first peer-reviewed data on CS014, highlighting antithrombotic efficacy without bleeding risk
14 January 2026 - Biotechnology company Cereno Scientific (Nasdaq First North: CRNO B) on Wednesday reported publication of the first peer-reviewed manuscript on its HDAC inhibitor CS014 in the Journa...
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboratio...
Organon signs commercialisation agreement for Nilemdo across six European markets
8 January 2026 - US healthcare company Organon (NYSE:OGN) announced on Thursday that it has entered into a commercialisation agreement with Daiichi Sankyo Europe to distribute and promote Nilemdo in F...
Antin to acquire clinical trial equipment provider Emsere
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emse...
GSK wins European Commission approval for Shingrix prefilled syringe
7 January 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Wednesday that the European Commission has approved a prefilled syringe presentation of its shingles vaccine Shin...